Forecast Of The Day: Estee Lauder Skin Care Revenues
What?
Estee Lauder (NYSE:EL) Skin Care Revenues rose from around $6.6 billion in 2019 to about $7.4 billion in 2020. Trefis expects the metric to rise to about $9.5 billion in 2021 and to around $11 billion by 2022.
Why?
- What’s Next For Estee Lauder Stock After A 17% Fall In A Month?
- Should You Buy Estee Lauder Stock After A 36% Decline Since 2021?
- Here’s How Estee Lauder Stock Has Managed To Outperform The S&P Since 2018
- Estee Lauder Stock Looks Set To Bounce Back From A 13% Drop Last Month
- Estee Lauder Stock: Up 1.85x Since 2018 Due To Rising Investor Expectations
- Down 4% Last Week, Will The Tides Turn For Estee Lauder Stock Soon?
We expect growth to be driven by Estee Lauder’s successful expansion into emerging markets, combined with growth in the premium cosmetics segment.
So What?
We think EL stock is slightly undervalued. We value EL at about $372, about 5% ahead of the current market price.
While we think EL stock has some upside, it is helpful to see how its peers stack up. Check out Estee Lauder Stock Comparison With Peers to see how FCEL stock compares against peers on metrics that matter. You can find more useful comparisons on Peer Comparisons.
See Our Complete Analysis For Estee Lauder
What if you’re looking for a more balanced portfolio instead? Here’s a high-quality portfolio that’s beaten the market consistently since the end of 2016.
| Returns | Jan 2022 MTD [1] |
2022 YTD [1] |
2017-22 Total [2] |
| EL Return | -4% | -4% | 365% |
| S&P 500 Return | -1% | -1% | 110% |
| Trefis MS Portfolio Return | -5% | -5% | 274% |
[1] Month-to-date and year-to-date as of 1/7/2022
[2] Cumulative total returns since the end of 2016